Centro Médico Teknon
Centro Médico Teknon
Spain, Barcelona
Agusti Barnadas Molins
41 years of experience
Clinic is certified :
Ovarian cancer treatment cost in Spain typically ranges from $20,000 to $35,000 for primary surgical intervention. Necessary diagnostics like a PET/CT scan run from $1,300 to $1,800, while specialized chemotherapy for ovarian cancer costs between $1,100 and $5,700. Total expenses depend on the disease stage and required cycles, offering 40-60% savings compared to the US. Leading medical hubs include Barcelona, Madrid, and Pamplona.
Typical Ovarian Cancer Treatment Costs in Spain
Bookimed Expert Insight: Advanced stage patients benefit from the high-tech infrastructure at JCI-accredited centers like Centro Médico Teknon. For those requiring complex surgical intervention, Teknon performs over 23,500 operations annually using robotic technologies. Patients seeking clinical trials should consider Quironsalud Madrid, a member of the GCIG Spanish sub-group. This provides access to novel protocols often unavailable in standard private clinics.
| Turkey | Austria | Spain | |
| Оophorectomy | from $2,943 | from $15,000 | from $9,500 |
| Radiation therapy for colorectal cancer | from $7,000 | from $12,000 | from $10,000 |
| Ovarian cancer surgery | from $9,243 | from $25,000 | from $20,000 |
| Omentectomy | from $4,500 | from $15,000 | from $12,000 |
| Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | from $22,500 | from $40,000 | from $25,000 |
Dr. Enrique Grande is a renowned medical oncologist at Hospital Ruber Internacional in Madrid. He has authored over 300 peer-reviewed scientific publications. Dr. Grande focuses on genitourinary and rare endocrine tumors. He serves as a pioneer in precision oncology and molecular profiling.
Dr. Joseba Rebollo Liceaga brings over 36 years of experience of oncology experience, specializing in advanced ovarian cancer treatments at Quironsalud Torrevieja.
Principal Investigator in multiple clinical trials for ovarian, cervical, and endometrial cancer – Dr. Oaknin brings advanced research directly to patient care.
Dr. Lucía González Cortijo is the Head of Medical Oncology at Hospital Universitario Quirónsalud Madrid. She specializes in breast and gynecologic cancers, including ovarian and cervical malignancies. Dr. González Cortijo holds a PhD cum laude and a Master’s in Molecular Oncology. She focuses on precision oncology, immunotherapy, and targeted treatments.
Leading Spanish centers for ovarian cancer include Clinica Universidad de Navarra and Centro Medico Teknon. These facilities hold JCI accreditation and offer advanced technologies like HIPEC and DaVinci robotic surgery. Specialists such as Dr. Ana Oaknin and Dr. Lucia Gonzalez Cortijo lead clinical trials for personalized therapies.
Bookimed Expert Insight: Spain ranks 4th globally in patient requests through our platform, reflecting high trust in its oncology infrastructure. While major centers like Clinica Universidad de Navarra serve 140,000 yearly patients, smaller specialized units often provide faster access to robotic systems. Dr. Ana Oaknin at Hospital Quiron Barcelona is a standout for patients seeking access to global clinical trials.
Patient Consensus: Patients note that traveling to major hubs like Madrid or Barcelona is necessary to access specialized robotic surgery. Those choosing private facilities emphasize the advantage of skipping long wait times common in public systems to begin treatment within weeks.
Spanish oncology centers utilize robotic-assisted systems like Da Vinci Xi and heated chemotherapy (HIPEC) to improve surgical precision. These technologies allow surgeons to perform complex debulking while preserving healthy tissue. Facilities often hold JCI accreditation and Newsweek rankings for clinical excellence.
Bookimed Expert Insight: Data shows a concentration of surgical expertise in Barcelona and Madrid. Centers like Centro Médico Teknon and HM Hospitales Madrid handle over 23,000 operations annually. This high volume allows these facilities to maintain advanced infrastructure like the Da Vinci Xi system. Patients should prioritize clinics with multiple accreditations, such as JCI and EFQM, to ensure consistent safety protocols.
Patient Consensus: Patients note that robotic surgery at private centers in Barcelona and Madrid significantly reduces hospital stays. Many emphasize that while HIPEC isn't universal, it is highly valued for high-recurrence cases.
Spanish oncology centers report a 90% to 95% 5-year survival rate for Stage I ovarian cancer. Advanced cases show approximately 30% to 41% survival at Stage III. Efficacy is driven by specialized surgery and targeted therapies like Olaparib, which reduces progression risk by 70%.
Bookimed Expert Insight: Spain’s oncology landscape is defined by massive patient volumes and specialized academic research. HM Madrid alone serves 2.3 million outpatients annually. This high volume allows doctors like Dr. Ana Oaknin to lead over 100 peer-reviewed trials. Such expertise is vital because Spanish data shows 5-year survival drops from 70% in younger women to 19% in seniors. Choosing a research-heavy center like Clinica Universidad de Navarra ensures access to these trial-based protocols for complex cases.
Patient Consensus: Patients note that while early detection remains difficult, the precision of robotic surgery at major centers is excellent. Many emphasize that religious tracking of CA-125 markers and joining support groups is essential for managing long-term recovery.
Patients should plan to stay in Spain for 14 to 21 days after major ovarian cancer surgery. This includes 3 to 7 days of hospitalization followed by local observation. Most airlines require a medical fit-to-fly certificate if traveling within 14 days of abdominal procedures.
Bookimed Expert Insight: While general medical guidelines suggest a 14-day stay, specialized packages in Madrid like those at Hospital Ruber Internacional recommend up to 45 days for complex recovery. This extended period accounts for advanced molecular profiling and coordination of systemic therapies that often follow surgical debulking.
Patient Consensus: Patients emphasize the need for flexible accommodation near the clinic. They note that common issues like fatigue and gas pain often make the minimum 2-week stay feel rushed.
International patients can join ovarian cancer clinical trials in Spain if they meet specific trial protocols. Facilities like Quironsalud Madrid offer free treatment through trials for eligible candidates. Success depends on tumor markers, previous treatments, and the ability to remain in Spain for long-term monitoring.
Bookimed Expert Insight: Spanish oncology centers handle massive patient volumes, with Clinica Universidad de Navarra serving 700,000 people annually. This high throughput makes Spain a primary hub for Phase II and III trials. Patients should target clinics like Quironsalud Madrid where clinical trials are a noted feature. These institutions often have the infrastructure to evaluate international medical records for trial suitability faster than smaller public hospitals.
Patient Consensus: Patients emphasize that residency and health cards are often bigger hurdles than medical criteria. Many recommend focusing on private research institutes in Barcelona or Madrid to bypass local public system restrictions.
Minimally invasive surgery is a widely available option for early-stage ovarian cancer in Spain. Surgeons use laparoscopic or robotic-assisted techniques to perform staging and fertility-preserving procedures. Centers like Centro Médico Teknon and Hospital Quirón Barcelona utilize the Da Vinci Xi system for high-precision oncological operations.
Bookimed Expert Insight: While major centers like Hospital Universitario HM Madrid serve over 70,000 inpatients annually, specific robotic expertise varies by city. Data shows that Barcelona and Madrid host the highest concentration of JCI-accredited facilities, where surgeons often combine robotized surgeries with advanced diagnostics like PET-CT to ensure complete tumor staging.
Patient Consensus: Patients note that robotic surgery is more accessible at private clinics in Madrid and Barcelona to avoid waitlists. They emphasize checking a surgeon's specific volume of minimally invasive cases before committing to a procedure.
Barcelona and Madrid host the highest concentration of English-speaking oncology teams in Spain. These cities feature JCI-accredited hubs like Centro Medico Teknon and Hospital Ruber Internacional. Specialized departments often employ US-trained specialists. This ensures fluent communication for complex ovarian cancer treatments and clinical trials.
Bookimed Expert Insight: While Madrid and Barcelona are primary hubs, Clinica Universidad de Navarra in Pamplona serves 700,000 international patients. It holds the first US-equivalent JCI certificate in Spain. This indicates a high level of English-speaking infrastructure despite being outside the largest metropolitan areas. This center reports a high 74% cure rate for complex sarcomas.
Patient Consensus: Patients note that choosing private centers helps avoid the need for translators required in public hospitals. Experienced teams in Madrid and Barcelona are specifically praised for explaining PARP inhibitor trials clearly in English.
Spanish ovarian cancer protocols combine cytoreductive surgery and platinum-based chemotherapy within JCI-accredited centres. Specialists often use hyperthermic intraperitoneal chemotherapy (HIPEC) to treat microscopic abdominal cells. Specialists like Dr Lucía González Cortijo and Dr Ana Oaknin use targeted PARP inhibitors and immunotherapy based on genetic profiling.
Bookimed Expert Insight: Spain’s oncology network shows a strong focus on high-volume efficiency. Hospital Universitario HM Sanchinarro alone treats 400,000 patients annually. This massive throughput allows Spanish specialists to manage complex cases that smaller centres rarely see. Australian patients benefit from doctors like Dr Enrique Grande. He integrates molecular profiling into standard care to pinpoint which biological therapies work best.
Patient Consensus: Patients in Spain note that doctors explain clinical details clearly in simple language. Reliable translation services help people understand every part of the multidisciplinary treatment plan during appointments.
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is available for ovarian cancer treatment in Spain. Leading JCI-accredited facilities offer this heated chemotherapy during surgery to treat recurrent cases. Specialised teams at centres like Hospital Quiron Barcelona and Quironsalud Madrid deliver these targeted treatments.
Bookimed Expert Insight: Spain ranks fourth globally in oncology requests. This volume is driven by major research hubs like Quironsalud, which has over 800 doctors. Patients with complex ovarian cases often choose Barcelona. This city houses top-ranked specialists who lead international clinical trials and GEICO research groups.
Patient Consensus: Patients find the Spanish medical system accessible and easy to navigate with translation support. Those visiting Barcelona note that specialists explain surgical options well and answer every clinical question clearly.
Robot-assisted surgery is not common for ovarian cancer in Spain but is available for specific cases. Open surgery remains the standard for advanced stages. Specialists use robotic systems like Da Vinci primarily for early-stage staging, fertility-sparing procedures, or specific interval debulking.
Bookimed Expert Insight: Spain’s top oncology centres prioritise surgical volume over the robot itself. While clinics like Hospital Quiron Barcelona and Clinica Universidad de Navarra serve over 40,000 patients annually, they select robotic platforms only when scans confirm the cancer is localised. For complex cases, these centres favour open debulking to ensure total tumour removal.
Patient Consensus: Patients in Spain note that finding a gynaecological oncologist is more important than the robot. They suggest confirming if robotic surgery fits the specific cancer stage before booking.
Spain hosts globally recognised gynaecological oncologists such as Dr Ana Oaknin at Hospital Quiron Barcelona. Another noted specialist is Dr Antonio González-Martín at Clinica Universidad de Navarra. They lead international clinical trials and research at JCI-accredited facilities. They specialise in cytoreductive surgery, HIPEC, and precision immunotherapy for ovarian cancer.
Bookimed Expert Insight: Spanish oncology centres like Clinica Universidad de Navarra and Hospital Quiron Barcelona show academic integration. Dr Ana Oaknin and Dr Lucía González Cortijo hold PhDs and lead international trials. This research focus lets patients access targeted therapies and immunotherapy protocols early. These are often available here before they become standard care elsewhere.
Patient Consensus: Patients at Hospital Quiron Barcelona note that specialists explain complex diagnosis details clearly. They also emphasise that using professional translators during oncology appointments helps clarify treatment steps.
Australian patients should plan for 14 to 42 days in Spain for ovarian cancer surgery. Open procedures require 21 to 42 days. Robotic or laparoscopic surgeries typically allow for a 14-day stay. This allows for safe recovery and fit-to-fly clearance.
Bookimed Expert Insight: Hospital discharge happens quickly, but the long flight to Australia poses a blood clot risk. Leading Spanish surgeons, like Dr Lucía González Cortijo at Quironsalud Madrid, often require a 3-week local stay. This buffer ensures wound healing. It also lets the team manage any delayed bowel recovery before the 20-hour flight.
Patient Consensus: Patients in Spain note that recovery is best managed in weeks rather than days. They emphasise keeping return flights flexible. This allows for wound checks, drain management, and delayed pathology results.
Madrid and Barcelona serve as Spain's primary hubs for ovarian cancer treatment. These cities house JCI-accredited facilities like Centro Médico Teknon and Hospital Ruber Internacional. They offer therapies such as HIPEC, PIPEC, and robotic-assisted surgeries performed by gynaecological oncologists.
Bookimed Expert Insight: Madrid and Barcelona lead in volume. However, Clinica Universidad de Navarra in Pamplona often tops quality rankings. Our data shows it treats patients from 70 different countries. This makes it a strong choice for Australians seeking a facility experienced with international medical logistics.
Patient Consensus: Patients note Madrid and Barcelona offer the most infrastructure for complex cases. They emphasise choosing specific specialists like Dr Lucía González Cortijo. They also note that a translator helps them understand all technical medical details during appointments.
International patients manage language barriers in Spain through dedicated international departments, bilingual medical staff, and professional interpreters. Leading JCI-accredited hospitals in Madrid and Barcelona employ coordinators. These specialists translate medical records and manage scheduling. They also accompany patients during oncology consultations so surgical plans and treatments are understood.
Bookimed Expert Insight: Spain ranks fourth globally in patient requests served. This is largely due to its concentrated private hospital networks. Centres like Hospital Ruber Internacional and Hospital Quiron Barcelona perform over 23,000 operations annually. This scale allows them to fund multilingual support staff that smaller clinics cannot sustain. Patients should choose clinics in Madrid or Barcelona for the best chance of English-speaking bedside nursing.
Patient Consensus: Patients highlight that while apps help with basic symptoms, professional translators are essential for discussing complex clinical studies. Bringing a written list of questions in both languages helps reduce stress during discharge and pharmacy visits in Spain.